key: cord-0884277-pyz2tnhk
authors: Popkin, Barry M.; Du, Shufa; Green, William D.; Beck, Melinda A.; Algaith, Taghred; Herbst, Christopher H.; Alsukait, Reem F.; Alluhidan, Mohammed; Alazemi, Nahar; Shekar, Meera
title: Individuals with obesity and COVID‐19: A global perspective on the epidemiology and biological relationships
date: 2020-08-26
journal: Obes Rev
DOI: 10.1111/obr.13128
sha: a75e09e0c2d66b9a44c296e9e448a9cbf6053140
doc_id: 884277
cord_uid: pyz2tnhk

The linkage of individuals with obesity and COVID‐19 is controversial and lacks systematic reviews. After a systematic search of the Chinese and English language literature on COVID‐19, 75 studies were used to conduct a series of meta‐analyses on the relationship of individuals with obesity–COVID‐19 over the full spectrum from risk to mortality. A systematic review of the mechanistic pathways for COVID‐19 and individuals with obesity is presented. Pooled analysis show individuals with obesity were more at risk for COVID‐19 positive, >46.0% higher (OR = 1.46; 95% CI, 1.30–1.65; p < 0.0001); for hospitalization, 113% higher (OR = 2.13; 95% CI, 1.74–2.60; p < 0.0001); for ICU admission, 74% higher (OR = 1.74; 95% CI, 1.46–2.08); and for mortality, 48% increase in deaths (OR = 1.48; 95% CI, 1.22–1.80; p < 0.001). Mechanistic pathways for individuals with obesity are presented in depth for factors linked with COVID‐19 risk, severity and their potential for diminished therapeutic and prophylactic treatments among these individuals. Individuals with obesity are linked with large significant increases in morbidity and mortality from COVID‐19. There are many mechanisms that jointly explain this impact. A major concern is that vaccines will be less effective for the individuals with obesity.

For persons with coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), there appears to be a strong relationship between being an individual with overweight or obesity and the risks of hospitalization and needing treatment in intensive care units (ICUs). Emerging literature suggests that adults with obesity under the age of 60 are more likely to be hospitalized. 1 The COVID-19 pandemic has occurred at a time when the prevalence of individuals with overweight/obesity is increasing in virtually all countries globally. In fact, almost all countries today have a prevalence of individuals with overweight/obesity greater than 20%. [2] [3] [4] To date, no country has experienced a reduction in the prevalence of individuals with overweight/obesity.

In addition, policy responses for mitigating COVID-19 are creating major economic hardships. The COVID-19 pandemic has brought to all countries the need to restrict movement, implement social distancing and impede economic activities across a broad spectrum of nonessential occupations. These adjustments have caused food system problems, including changes in food consumption and physical activity patterns, and remote telework environments that may exacerbate current trends in the prevalence of individuals with obesity, while another effect will be to increase the proportion food insecure and also those stunted and malnourished. These changes have long-lasting implications beyond the mitigation of the current SARS-CoV-2 spread and may be detrimental to people's health.

The association between individuals with excessive body fat, especially visceral adipose tissue; individuals with obesity; major cardiometabolic problems, ranging from hypertension to cardiovascular disease to type 2 diabetes (T2D); and a number of cancers is strong. [5] [6] [7] [8] The underlying metabolic and inflammatory factors of individuals with obesity also play a considerable role in the manifestation of severe lung diseases. Susceptibility to acute respiratory distress syndrome (ARDS), the primary cause of COVID-19 mortality, is significantly greater among individuals with obesity. 9 Importantly, being an individual with obesity independently increases the risk of influenza morbidity and mortality, 10 most likely through impairments in innate and adaptive immune responses. 11 Potentially the vaccines developed to address COVID-19 will be less effective for individuals with obesity due to a weakened immune response.

In this paper, we first highlight the epidemiological data that provide insight into the relationship between being an individual with overweight/individuals with obesity and COVID-19, undertaking when possible meta-analyses of the published data. We provide an overview of the current understanding of how individuals with obesity affect the immunological and physiological response to SARS-CoV-2.

We follow this with a discussion of the issues of income distribution, food insecurity and the major dietary shifts we are seeing globally. For the latter, we rely on reviews and reports from some key sources of industry sales data, as no solid primary data sources are available. Our discussion includes dietary and activity issues linked with COVID-19 that might exacerbate individuals with obesity and some of the potential policies that can address this issue.

The prevalence of individuals with overweight/obesity is at an all-time high and is increasing across the globe. This is true not only in higher income countries but also in low-and middle-income countries with high levels of undernutrition leading to the double burden of malnutrition. 4, 12 Few low-and middle-income countries have a prevalence of individuals with overweight/obesity less than 20% among their adult populations. Figure 1 shows a map of the world in the 1990s and the late 2010s.

A large proportion of the populations in higher income countries are overweight or obese. As Figure 1 shows, few higher income countries have adult populations with a prevalence of overweight/obese less than 70%. This prevalence is not declining in any country. In higher income countries, the prevalence of individuals with overweight/obesity was already high in the 1990s, and it has continued to increase. In fact, larger portions of their populations have become individuals with morbid obesity with body mass indexes (BMIs) over 35-40 kg m −2 . In low-and middle-income countries outside of Latin America and a number of small islands, the growth in individuals with overweight/obesity has occurred primarily in the past several decades from 1990 to 2020 which we and many others have documented. 2, 3, [13] [14] [15] [16] Further, evidence shows that >70% of the individuals with overweight/obesity live in low-or middle-income countries, and as country economies grow, the burden of individuals with obesity shifts to the poor. [17] [18] [19] In the Middle East and Latin America, the prevalence of rates of individuals with obesity are among the highest in the world.

Two related factors are equally important. First, we are finding that much of the BMI increase accompanies an increase in central adiposity proxied by waist circumference at all ages compared with the amount of such adiposity one or two decades earlier. [20] [21] [22] Second, across the globe, the economically poor are more prone to develop obesity than are the rich. [17] [18] [19] 23 F I G U R E 1 Prevalence of overweight and obesity based on 1990s and late 2010s weight and height data

This review study is exempted from IRB review, and there was no public or patient involvement.

We examined PubMed, Google Scholar, MedRxiv, BioRxiv, Wanfang (for Chinese literature) and other literature search engines (e.g., China National Knowledge Infrastructure Data and ICNARC) to systematically review all publications in Chinese or English that include data on COVID-19 and BMI or individuals with obesity. We briefly reviewed the abstracts and results and located 75 publications available by 15 July 2020 that presented data on the BMIs or BMI categories of diagnosed COVID-19 patients. We excluded literature in other languages, as we read Chinese and English only. All of our authors performed the literature searches and reviews. 

We found 1733 studies, 75 of which provided data we could use in this review ( Figure 2 ). All were conducted between January and June 2020, including five case-control studies, 33 retrospective or prospective cohort studies and 37 observational cross-sectional studies.

Sample sizes varied from 24 to 109 367 diagnosed patients in more than 10 countries in Asia, Europe and North and South America. In total, we included 399 461 diagnosed patients in this study, about 55% of whom were male. Table S2 presents detailed demographic data from the studies we used, including a few studies that had inadequate data for use in the meta-analysis. We used STATA (version 16, College Station, TX) to perform all random-effects meta-analysis and used residual maximum likelihood to fit all models. 24 

We identified 20 studies that assessed the association between individuals with obesity and COVID-19, all but two of which showed that individuals with obesity significantly increase the risk of COVID-19 (Table S3) . [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] One study in Denmark showed that the prevalence of overweight and individuals with obesity was lower in SARS-CoV-2 positive cases than SARS-CoV-2 test-negative individuals (8.6%

vs. 9.9%). 44 The results may be biased because body weight status was determined at hospital discharge. A study used U.K. Biobank data CI, 1.46-2.65; p < 0.0001), adjusted for age, sex, ethnicity and socioeconomic deprivation as measured by unemployment, assets and household density. 32 The authors tested only a small portion of individuals (0.5%) for COVID-19, a key limitation of this study. A better way to calculate OR for this study is to compare the odds between subjects who tested positive and those who tested negative. Our pooled data analysis showed that the odds of individuals with obesity being COVID-19 positive were 46.0% (OR = 1.46; 95% CI, 1.30-1.65; p < 0.0001) higher than those of individuals who were not obese ( Figure 3 ).

Being an individual with obesity increases the odds of COVID-19 patients being hospitalized. Among diagnosed COVID-19 patients, the prevalence of individuals with obesity in hospitalized patients was much higher than that in nonhospitalized patients. For example, a report that included 5700 patients with obesity in New York City 45 showed that 41.7% of COVID-19 hospitalized patients were individuals with obesity, whereas the average prevalence of individuals with obesity in New York City was 22.0%. 46 Many studies reported COVID-19 hospitalizations, but only a few reported the relationship between individuals with obesity and hospitalization. We identified 19 studies that examined the relationship and included them in this analysis. 1, 28, 38, 40, 44, [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] Table S4 presents the results 1, 45, 47, 48, 59, 60 ; all showed a significantly higher prevalence of individuals with obesity among hospitalized patients than among patients not hospitalized or the general population.

The pooled OR was 2.13 (95% CI, 1.74-2.60; p < 0.0001) ( Figure 4 ).

Among patients with symptoms, those with severe or critical conditions had much higher BMIs and individuals with obesity prevalence than the normal population or patients who were COVID-19 negative. 32, [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] Two studies showed that the odds of having COVID-19 increased by 30% (OR = 1.30; 95% CI, 1.09-1.54; p = 0.0030) 61 and by 38% (OR = 1.38; p < 0.0001), 32 respectively, among the individuals with obesity ( Table 1 ).

All studies reported that among those diagnosed, patients with obesity were more likely to be admitted to ICUs. * However, the effect sizes in the studies with smaller sample sizes were not statistically significant. 48, 72, 73 In the studies that found that being an individual with obesity did not significantly increase the odds of being admitted to the ICU, individuals with morbid obesity (defined as BMI ≥ 35) did significantly increase the odds of ICU admittance. Our pooled data (from 22 studies) showed that individuals with obesity increased the odds of being admitted to the ICU by 74% (OR = 1.68; 95% CI, 1.46-2.08; p < 0.0001) ( Figure 5 and Table S5 ).

Reports that had smaller sample sizes from the United Kingdom and some other countries showed that patients with obesity had higher but insignificant odds of invasive mechanical ventilation (IMV) than patients without obesity. 48, 72, 86 Reports from Mexico and some U.S. cities showed significantly higher odds of IMV in patients with obesity than in patients without obesity. † The pooled data (from 14 studies) showed a 66% increase in IMV in patients with obesity (OR = 1.66; 95% CI, 1.38-1.99; p < 0.0001) ( Figure 6 and Table S6 ).

The association between obesity and COVID-19 prognosis is complex, because patients discharged from ICUs may be still hospitalized or deceased later. For example, 4.5% died after they were discharged from ICU; 11.5% remained in the hospital after leaving the ICU in one study. 31 A few studies showed that individuals with F I G U R E 4 Meta-analysis of the association between individuals with obesity and the risk of hospitalization with COVID-19 Figure 7 and Table S7 ). ‡ We excluded two studies that had very large OR and very wide 95% CI, one study in China (OR = 32.08; 95% CI, 6.73-153) 65 

Being an individual with obesity is associated with numerous underlying risk factors for COVID-19, including hypertension, dyslipidaemia, type 2 diabetes (T2D) and chronic kidney or liver disease. Coronaviruses are typically not associated with severe disease and were mostly thought to cause only mild respiratory infections until the emergence of the 2002 severe acute respiratory syndrome coronavirus (SARS-CoV) in Guangdong, China. The SARS-CoV outbreak was ultimately contained thanks to its low viral load within the beginning stages of symptom onset, allowing time for identification and isolation of infected individuals. 107 The 2009 influenza pandemic, caused by an outbreak of the upper respiratory influenza A H1N1 virus, identified individuals with obesity as an independent risk factor for severe influenza morbidity and mortality. 10 Subsequently, emergence of the Middle East respiratory syndrome coronavirus (MERS-CoV) in 2012 exhibited high prevalence among individuals with obesity. 108 The growing evidence detailed above demonstrates that obesity increases the risks of hospitalization, severity and in some cases death with viral respiratory infections, increasing the likelihood that obesity may also independently increase the risk for COVID-19, another respiratory viral disease. Several reports summarize the current understanding of the pathogenicity and immune response to SARS-CoV-2 based on available data from animal and human studies. 109 

Being an individual with obesity is a major risk factor for severe cases of certain infectious diseases, like influenza, hepatitis and nosocomial infections. 111 Hyperglycaemia, a key hallmark of T2D, is highly associated with individuals with obesity. Importantly, uncontrolled serum glucose has been shown to significantly increase COVID-19 mortality. 116 

Being an individual with obesity has modulatory effects on key immune cell populations critical in the response to SARS-CoV-2. liver, heart and kidneys. 109, 142 This mechanism is thought to drive increased incidence of ischemic and coagulopathy conditions in COVID-19 patients.

ARDS and acute lung injury (ALI) are two of the primary causes of morbidity and mortality among adults infected with SARS-CoV-2. 143 Presentation of ARDS and ALI is characterized by respiratory failure due to excessive pro-inflammatory cytokine production. This inflammatory state leads to extensive lung damage, hypoxemic respiratory failure regardless of oxygen administration and pulmonary oedema not caused by congestive heart failure. 144 Men also experience a higher burden of COVID-19 than women. 59 Being a man with obesity increases aromatase activity, which can convert testosterone to estradiol. 152 Oestrogen receptor signalling can subsequently down-regulate IL-6 expression through inhibition of NF-κB, 153 which has been shown to confer protective effects against influenza A virus in women through stimulation of neutrophil and virus-specific CD8 T cell responses. 154 Interestingly, however, men with obesity have impaired oestrogen receptor signalling, which leads to increased androgenic hormones and elevated oestrogen production from adipose tissue. 155 Recently, androgen depletion therapy has been shown to protect against COVID-19 in male prostate cancer patients. 156 However, more information is needed to understand the mechanism of action of androgens and androgen depletion therapy. Nonetheless, adequate control of proand anti-inflammatory responses during SARS-CoV-2 infections is critical to limit nonspecific tissue damage and subsequent development of ARDS, which has a higher burden among COVID-19 cases with obesity.

Obesity may also impair therapeutic treatments during COVID-19

infections. ACE inhibitors, which are commonly used to treat hypertension, may increase COVID-19 severity in T2D patients, especially those with poorly controlled blood glucose. 157 While discontinuing use of ACE inhibitors is not advisable at this time due to offsetting cardiovascular benefits, 158 binding. How these treatments in patients with obesity contribute to COVID-19 severity, however, will be a key question in their overall effectiveness. The IL-6 receptor (IL-6R) antagonist tocilizumab may reduce IL-6 signalling in severe COVID-19 cases where cytokine release syndrome is a major factor of mortality. 159 As noted above, chronic inflammation is a hallmark of individuals with obesity, which includes elevated levels of IL-6. Preliminary data suggest tocilizumab treatment can reduce fever and oxygen requirement. 160 middle-income countries. 174 The impact on not only malnutrition but increased food insecurity for the large proportion of lower income families is expected to be significant. 174 One might suspect we would see a decline in obesity if the food insecurity impacts the individuals with overweight and obesity in many low-and middle-income countries. This truly depends on how serious is the food insecurity and loss of income and how are diets shifted, if at all. We will see diet shifts in not only how we eat and drink but also how we move if inactivity grows greatly. If the diets shifts to increased consumption of refined carbohydrates, fried food and other unhealthy aspects of the traditional diet or to increased highly or ultraprocessed food we may experience increases in the prevalence of individuals with obesity. One can speculate but we truly do not know. Surveys on this topic are not published to date. Similarly studies in higher income countries suggest weight gains or no shift in weight. 175 At the same time, some studies from higher income countries suggest potential increases in obesity. 175, 176 While we do not have data on sales of ultraprocessed foods and beverages, many reports both from organizations monitoring food purchases and global company reports suggest that in higher and middle-income countries access to fresh foods, especially fruits and vegetables is impacted due to breakdowns in local supply chains, and the demand for packaged processed food has increased, especially in the ready-to-eat and -drink categories. 8, 177 These foods tend to be ultraprocessed and high in energy density, saturated fat, sodium and sugar. The attraction is partially that these foods require less storage and are highly palatable. In addition, they are relatively inexpensive due to the large economies of scale in their production. Particularly where costs loom greatly in food-purchasing decisions, as among the lower income segments of the population, these cheaper products may be consumed in much greater quantities. However, ultraprocessed foods are a major contributor to obesity and other non-communicable diseases (NCDs). The literature linking ultraprocessed foods with adverse health outcomes is large and consistent. [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] Additionally 

Vaccination remains the best protection against infectious diseases like COVID-19. Therapeutics targeted at limiting viral replication or remediating complications of infection may help limit severe cases and moderately reduce mortality. Public health experts agree that viral spread will continue to cause tremendous health and economic problems until we reach vaccination and/or community-acquired herd immunity. Current models project that intermittent times of social distancing and lockdown measures will be required until a viable vaccine can be widely produced, 197 and these measures are likely to extend into the foreseeable future. This paper highlights another concernthat is, vaccines may not be as effective in individuals with overweight/obesity. Given the large prevalence of the world population that is composed of individuals with overweight/obesity, it is imperative that governments ensure that testing and research focus not only on the general efficacy of vaccines and therapeutics but also on how they will impact individuals with obesity.

Furthermore, we must carefully monitor and regulate the consumption of ultraprocessed foods and beverages through fiscal policies such as taxation and regulating marketing and promotion of such foods. If as expected this behaviour is increasing, it will exacerbate other health concerns, including risks of increased adiposity and major

NCDs. When compounded with reduced physical activity and increased sedentary behaviour, the risk of increased adiposity is clearly an important concern. Finally, the poor around much of the globe also face increased hunger and with it the potential for elevated stunting and its consequences, including the long-term risks of central visceral adiposity and many NCDs. Increasing hunger and stunting can have long-term adverse impacts on health and well-being in multiple ways, and major policies to mitigate this effect are critical when resources are available.

In addition to COVID-19's critical economic constraints, its impacts on diets may pose lifelong risks to populations around the globe. Food habits developed during this period, particularly the intake of ultraprocessed foods, represent a major health risk. Exact policy prescriptions will be country specific, and clearly, the concerns for higher and middle-income countries will differ from those of lowincome countries. NCD and individuals with obesity risks are far more predominant in the former, whereas the latter face high levels of the double burden of malnutrition, in which slow declines in stunting are likely to shift to increased stunting and wasting accompanied by rapid increases in individuals with obesity.

Creative policies to reduce consumption of ultraprocessed foods and increase consumption of healthier foods, such as legumes, selected whole grains, vegetables and fresh fruits, are important for all countries. A recent World Bank report suggests that the multipurpose Chilean model effectively administers multiple regulations and laws that reinforce each other and are impactful. 12, 198, 199 It is quite that likely Chile's policies could significantly reduce the current growth in consumption of ultraprocessed foods. Moreover, a tax accompanying purchases of those foods would potentially increase fiscal space in countries suffering from the economic impacts of COVID-19, albeit few countries have successfully allocated these resources for health or nutrition programmes. Some countries are finding ways to provide boxes of fresh vegetables and fruits to the elderly such as one programme in several Chilean cities 200 ; however, most low-and middleincome countries do not have the resources for such efforts though combined with taxation and marketing controls, such efforts would be more feasible. All countries need to consider how to enhance consumers' selections of healthy food options while reducing incentives to purchase ultraprocessed foods and beverages. To date, no country has combined these fiscal and regulatory policies. However, Israel's Chilean-style warning labels and promotion of healthy eating comes closest. 201 The COVID-19 pandemic challenges all countries enormously.

Our systems, institutions, health and welfare will feel the impacts for many years. The high prevalence of individuals with obesity exacerbates the threat to everyone's health, and the economic, social distancing and stay-at-home components compound the impacts. We will need creative solutions quickly to prevent undesirable dietary patterns and promote healthy eating, which is so critical to our future health and for building resilience against future threats.

Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission

Rising rural body-mass index is the main driver of the global obesity epidemic in adults

Trends in adult bodymass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 128.9 million participants

Dynamics of the double burden of malnutrition and the changing nutrition reality

World Cancer Research Fund/American Institute for Cancer Research. Diet, nutrition, physical activity and cancer: a global perspective (A summary of the third expert report)

World Cancer Research Fund/American Institute for Cancer Research. Diet, nutrition, physical activity and cancer: a global perspective

Obesity Collaborators. Health effects of overweight and obesity in 195 countries over 25 years

Covid-19: wave 2, 27-30 March among connected South African consumers

Body mass index is associated with the development of acute respiratory distress syndrome

A novel risk factor for a novel virus: obesity and 2009 pandemic influenza A (H1N1)

Chapter 10-influence of obesity on the response to influenza infection and vaccination

Obesity: Health and Economic Consequences of an Impending Global Challenge. Washington DC: The World Bank

Recent underweight and overweight trends by rural-urban residence among women in low-and middle-income countries

Recent dynamics suggest selected countries catching up to US obesity

The obesity epidemic is a worldwide phenomenon

New dynamics in global obesity facing lowand middle-income countries

Crossnational comparisons of time trends in overweight inequality by socioeconomic status among women using repeated cross-sectional surveys from 37 developing countries

Is the burden of overweight shifting to the poor across the globe? Time trends among women in 39 low-and middle-income countries (1991-2008)

Socioeconomic status and obesity in adult populations of developing countries: a review

Exploring secular changes in the association between BMI and waist circumference in Mexicanorigin and white women: a comparison of Mexico and the United States

Is waist circumference per body mass index rising differentially across the United States, England, China and Mexico

Changes in waist circumference relative to body mass index in Chinese adults

Weight of nations: a socioeconomic analysis of women in low-to middleincome countries

StataCorp LLC

Predictors of COVID-19 incidence, mortality, and epidemic growth rate at the country level

Smoking and the risk of COVID-19 infection in the UK Biobank Prospective Study

Predicting mortality due to SARS-CoV-2: a mechanistic score relating obesity and diabetes to COVID-19 outcomes in Mexico

Risk of infection and hospitalization by Covid-19 in Mexico: a case-control study

Vitamin D status, body mass index, ethnicity and COVID-19: initial analysis of the firstreported UK Biobank COVID-19 positive cases (n 580) compared with negative controls

Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study

ICNARC. ICNARC report on COVID-19 in critical care 10

Modifiable and nonmodifiable risk factors for COVID-19: results from UK Biobank

Associations with covid-19 hospitalisation amongst 406,793 adults: the UK Biobank prospective cohort study

Obesity is a risk factor for greater COVID-19 severity

Low plasma 25(OH) vitamin D3 level is associated with increased risk of COVID-19 infection: an Israeli population-based study

Comorbidities might be a risk factor for the incidence of COVID-19: evidence from a web-based survey of 780,961 participants

Health-care workers with COVID-19 living in Mexico City: clinical characterization and related outcomes

The natural history of symptomatic COVID-19 in Catalonia, Spain: a multi-state model including 109,367 outpatient diagnoses, 18,019 hospitalisations, and 5,585 COVID-19 deaths among 5,627,520 people

The association between obesity, type 2 diabetes, and hypertension with severe COVID-19 on admission among Mexicans

Characteristics and risk factors for COVID-19 diagnosis and adverse outcomes in Mexico: an analysis of 89,756 laboratory-confirmed COVID-19 cases

COVID-19 outcomes, risk factors and associations by race: a comprehensive analysis using electronic health records data in Michigan Medicine

Obesity is the comorbidity more strongly associated for Covid-19 in Mexico. A case-control study

Death by SARS-CoV2-a Romanian COVID-19 multi-centre comorbidity study

Characteristics and predictors of hospitalization and death in the first 9

Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area

Individuals with obesity

Factors associated with hospitalization and critical illness among 4,103 patients with COVID-19 disease in

Pre-existing characteristics associated with Covid-19 illness severity

Early estimation of the risk factors for hospitalisation and mortality by COVID-19 in Mexico

Lifestyle risk factors for cardiovascular disease in relation to COVID-19 hospitalization: a community-based cohort study of 387,109 adults in UK

What factors increase the risk of complications in SARS-CoV-2 positive patients? A cohort study in a nationwide Israeli health organization

Special report: prevalence of selected underlying health conditions among active component Army service members with coronavirus disease

A primary care approach to the COVID-19 pandemic: clinical features and natural history of 2,073 suspected cases in the Corona Sao Caetano programme

Clinical and epidemiological characteristics of patients diagnosed with COVID-19 in a tertiary care center in Mexico City: a prospective cohort study. Revista de investigacion clinica

Outcomes of COVID-19 in patients with obesity in United States: a large research network study

Prognostic factors in Spanish Covid-19 patients: a case series from Barcelona

In young adults with COVID-19, obesity is associated with adverse outcomes

Clinical characteristics and morbidity associated with coronavirus disease 2019 in a series of patients in metropolitan Detroit

Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019-COVID-NET, 14 states

Personalized predictive models for symptomatic COVID-19 patients using basic preconditions: hospitalizations, mortality, and the need for an ICU or ventilator

Early antiviral treatment contributes to alleviate the severity and improve the prognosis of patients with novel coronavirus disease (COVID-19)

Covid-19 in critically ill patients in the Seattle Region-case series

Prevalence of malnutrition and analysis of related factors in elderly patients with COVID-19 in Wuhan, China

Clinical characteristics of 30 medical workers infected with new coronavirus pneumonia

Clinical characteristics and outcomes of 112 cardiovascular disease patients infected by 2019-nCoV

High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation

Critical care for severe COVID-19: a population-based study from a province with low case-fatality rate in China

Characterization and clinical course of 1000 patients with COVID-19 in New York: retrospective case series

Ethnicity, comorbidity, socioeconomic status, and their associations with COVID-19 infection in England: a cohort analysis of UK Biobank data

Non-white ethnicity, male sex, and higher body mass index, but not medications acting on the renin-angiotensin system are associated with coronavirus disease 2019 (COVID-19) hospitalisation: review of the first 669 cases from the UK biobank

Global status report on noncommunicable diseases

Obesity and COVID-19 severity in a designated hospital in Shenzhen, China (3/13/2020)

Association of obesity with disease severity among patients with COVID-19

C-Reactive protein and SOFA score as early predictors of critical care requirement in patients with COVID-19 pneumonia in Spain

Interim analysis of risk factors for severe outcomes among a cohort of hospitalized adults identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET)

Is sleep apnoea a risk factor for Covid-19? Findings from a retrospective cohort study

Prevalence of obesity among adult inpatients with COVID-19 in France

COVID-19: impact of obesity and diabetes in disease severity

Epidemiological and clinical features of 2019-nCoV acute respiratory disease cases in Chongqing municipality, China: a retrospective, descriptive, multiple-center study

Derivation and validation of a predictive score for disease worsening in patients with COVID-19: the COMPASS-COVID-19 prospective observational cohort study

Obesity is associated with worse outcomes in COVID-19: analysis of early data from New York City

Risk Factors Associated with Severe COVID-19 in Eastern France: Analysis of 1045 Cases

Factors associated with hospitalization and disease severity in a racially and ethnically diverse population of COVID-19 atients

Obesity is associated with increased risk for mortality among hospitalized patients with COVID-19

Clinical course and potential predicting factors of pneumonia of adult patients with coronavirus disease 2019 (COVID-19): a retrospective observational analysis of 193 confirmed cases in Thailand

Obesity is associated with severe forms of COVID-19

Clinical characteristics of Covid-19 in New York City

Epidemiology, risk factors and clinical course of SARS-CoV-2 infected patients in a Swiss university hospital: an observational retrospective study

Demographics, comorbidities and outcomes in hospitalized Covid-19 patients in rural Southwest Georgia

Characteristics, outcome and predictors of in-hospital mortality in an elderly population from a SARS-CoV-2 outbreak in a long-term care facility

Lung disease severity, coronary artery calcium, coronary inflammation and mortality in coronavirus disease 2019

Obesity, overweight and survival in critically ill patients with SARS-CoV-2 pneumonia: is there an obesity paradox? Preliminary results from Italy

Fatality rate and predictors of mortality in a large Italian cohort of hospitalized COVID-19 patients

Ethnicity and risk of death in patients hospitalised for COVID-19 infection: an observational cohort study in an urban catchment area

A tertiary center experience of multiple myeloma patients with COVID-19: lessons learned and the path forward

Correlation of coagulation parameters with clinical outcomes in coronavirus-19 affected minorities in United States: observational cohort

Ethnic and regional variation in hospital mortality from COVID-19 in Brazil

A cohort of patients with COVID-19 in a major teaching hospital in Europe

Features of 16,749 hospitalised UK patients with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol

30-day mortality in patients hospitalized with COVID-19 during the first wave of the Italian epidemic: a prospective cohort study

Risk factors associated with clinical outcomes in 323 COVID-19 hospitalized patients in Wuhan, China

Survival in adult inpatients with COVID-19

Severe obesity, increasing age and male sex are independently associated with worse inhospital outcomes, and higher in-hospital mortality

Obesity as a risk factor for unfavourable outcomes in critically ill patients affected by Covid-19 related respiratory failure: clinical relevance and potential pathophysiological mechanism

Predicting the disease outcome in COVID-19 positive patients through machine learning: a retrospective cohort study with Brazilian data

Sociodemographic predictors of outcomes in COVID-19: examining the impact of ethnic disparities in Northern Nevada. medRxiv

From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses

Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis

Immunology of COVID-19: current state of the science

The trinity of COVID-19: immunity, inflammation and intervention

Individuals with obesity and the outcome of infection

Obesity and the risk and outcome of infection

Obesity paradox, obesity orthodox, and the metabolic syndrome: an approach to unity

Adipocytokines and the metabolic complications of obesity

Metabolic effects of obesity: a review

Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes

Molecular understanding of hyperglycemia's adverse effects for diabetic complications

Insulin receptormediated stimulation boosts T cell immunity during inflammation and infection

Leptin metabolically licenses T cells for activation to link nutrition and immunity

Metabolic regulation of immune responses

n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases

Polyunsaturated fatty acids and inflammation

Omega-3 fatty acids cause dramatic changes in TLR4 and purinergic eicosanoid signaling

Polyunsaturated fatty acids in the food chain in the United States

Hormonal dysregulation and unbalanced specialized pro-resolving mediator biosynthesis contribute toward impaired B cell outcomes in obesity

Importance of cholesterol-rich membrane microdomains in the interaction of the S protein of SARS-coronavirus with the cellular receptor angiotensinconverting enzyme 2

Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease

Obesity and impaired metabolic health in patients with COVID-19

Obesity is a risk factor for severe COVID-19 infection: multiple potential mechanisms. Circulation

Morbidly obese human subjects have increased peripheral blood CD4+ T cells with skewing toward a Treg-and Th2-dominated phenotype

Insulin inhibits IL-10-mediated regulatory T cell function: implications for obesity

Diet-induced obese mice exhibit altered heterologous immunity during a secondary 2009 pandemic H1N1 infection

Immunophenotyping of COVID-19 and influenza s the role of type I interferons in development of severe COVID-19

Role of innate and adaptive immunity in obesity-associated metabolic disease

Elevated proinflammatory cytokine production by a skewed T cell compartment requires monocytes and promotes inflammation in type 2 diabetes

T-cell profile in adipose tissue is associated with insulin resistance and systemic inflammation in humans

Th17 cytokines differentiate obesity from obesity-associated type 2 diabetes and promote TNFα production

Fatty acid metabolites combine with reduced β oxidation to activate Th17 inflammation in human type 2 diabetes

Is adipose tissue a reservoir for viral spread, immune activation, and cytokine amplification in coronavirus disease 2019?

Obesity expands a distinct population of T cells in adipose tissue and increases vulnerability to infection

The role of adipocytes and adipocyte-like cells in the severity of COVID-19 infections

SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor

Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China

Mechanisms and clinical consequences of acute lung injury

Obesity Paradox" in Acute Respiratory Distress Syndrome: Asystematic Review and Meta-Analysis

Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology

Middle East respiratory syndrome: emergence of a pathogenic human coronavirus

Interleukin-6 is a potential biomarker for severe pandemic H1N1 influenza a infection

Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study

Clinical and immunological features of severe and moderate coronavirus disease 2019

Overweight and obese adult humans have a defective cellular immune response to pandemic H1N1 influenza A virus

Obesity in men: the hypogonadal-estrogen receptor relationship and its effect on glucose homeostasis

Estrogen receptor inhibits interleukin-6 gene expression by disruption of nuclear factor kappaB transactivation

17β-Estradiol protects females against influenza by recruiting neutrophils and increasing virus-specific CD8 T cell responses in the lungs

Increased estrogen production in obese men

Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N = 4532)

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic

Pharmacotherapy in COVID-19; a narrative review for emergency providers

Cytokine release syndrome in severe COVID-19

Effective treatment of severe COVID-19 patients with tocilizumab

Effect of dexamethasone in hospitalized patients with Covid-19: preliminary report

Dexamethasone in the management of covid-19

Obesity is associated with impaired immune response to influenza vaccination in humans

Increased risk of influenza among vaccinated adults who are obese

Obesity outweighs protection conferred by adjuvanted influenza vaccination

Reduced tetanus antibody titers in overweight children

The weight of obesity on the human immune response to vaccination

Longitudinal evaluation and decline of antibody responses in SARS-CoV-2 infection

Duration of antibody responses after severe acute respiratory syndrome

Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals

Presence of SARS-CoV-2 reactive T cells in COVID-19 patients and healthy donors

SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls

SARS-CoV-2 T cell immunity: specificity, function, durability, and role in protection

Global nutrition report: action on equity to end malnutrition

COVID-19-related school closings and risk of weight gain among children

Eating habits and lifestyle changes during COVID-19 lockdown: an Italian survey

The impact of coronavirus on packaged and fresh food. Euromonitor International London

Association between consumption of ultra-processed foods and all cause mortality: SUN prospective cohort study

Ultraprocessed food consumption and risk of overweight and obesity: the University of Navarra Follow-Up (SUN) cohort study

Ultra-processed food consumption and adiposity trajectories in a Brazilian cohort of adolescents: ELANA study

Ultra-processed food consumption and the incidence of hypertension in a Mediterranean cohort: the Seguimiento Universidad de Navarra Project

Relationships between consumption of ultra-processed foods, gestational weight gain and neonatal outcomes in a sample of US pregnant women

Global trends in ultraprocessed food and drink product sales and their association with adult body mass index trajectories

Ultra-processed diets cause excess calorie intake and weight gain: an inpatient randomized controlled trial of ad libitum food intake

Ultra-processed food and adverse health outcomes

Ultra-processed food intake and risk of cardiovascular disease: prospective cohort study (NutriNet-Santé)

Consumption of ultra-processed foods and cancer risk: results from NutriNet-Santé prospective cohort

Consumption of ultra-processed food products and its effects on children's lipid profiles: a longitudinal study

Prospective association between ultra-processed food consumption and incident depressive symptoms in the French NutriNet-Santé cohort

Ultra-processed food consumption and its effects on anthropometric and glucose profile: a longitudinal study during childhood

Ultra-processed food consumption and the incidence of depression in a Mediterranean cohort: the SUN Project

Ultra-processed food intake and mortality in the USA: results from the Third National Health and Nutrition Examination Survey (NHANES III, 1988-1994)

Ultra-processed food consumption and chronic noncommunicable diseases-related dietary nutrient profile in the UK

Ultraprocessed food consumption and incident frailty: a prospective cohort study of older adults

Association between ultraprocessed food consumption and risk of mortality among middle-aged adults in France

Exploratory analysis of nutritional quality and metrics of snack consumption among Nepali children during the complementary feeding period

Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period

Structural responses to the obesity and non-communicable diseases epidemic: update on the Chilean law of food labelling and advertising

An evaluation of Chile's Law of Food Labeling and Advertising on sugarsweetened beverage purchases from 2015 to 2017: a before-andafter study

Strengthening local food systems in times of concomitant global crises: reflections from Chile

Policy and practice-regulatory measures to improve the built nutrition environment for prevention of individuals with obesity and related morbidity in Israel

We thank Rekha Menon, Practice Manager for Health, Nutrition and Population at the World Bank, for her support in the production of this article. We also thank Emily Busey for graphics support and Ariel Adams for administrative support.This article was funded under the Reimbursable Advisory Services Program between the Saudi Health Council and the World Bank.

Additional supporting information may be found online in the Supporting Information section at the end of this article.